Research shows significant disparities in cancer screening. Research suggests that Non-White people and LGBTQIA+ populations are screened at lower rates and at a later time when compared with Non-Hispanic White and non-LGBTQIA+, leading to cancer identification at later stages. Treatment choices are also affected by disparities, when non-White and LGBTQIA+ patients are offered less effective treatment options.
Front-line providers can improve identification, screening, and referral to address racism and disparities in cancer care. In this CME Outfitters presentation, expert faculty will discuss the impact of racial/ethnic and gender-based racism and discrimination on routine cancer screenings in addition to providing actionable strategies healthcare providers (HCPs) integrate into practice to improve disparities in cancer screenings for racial/ethnic groups, women, transgender patients, and non-binary individuals.
Supported by educational grant from CVS Health.
Physicians, nurses, pharmacists, pharmacy technicians, physician associates (PAs), nurse practitioners (NPs), and other health care clinicians within the CVS, Aetna, and CareMark networks.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Peek reports no financial relationships to disclose.
Ms. Bruessow reports no financial relationships to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).